Research Summary

My research concerns access, delivery, and organization of substance abuse treatment services. My experience in this area includes studies evaluating efforts to improve access to publicly funded drug abuse treatment, assessing federal policy to end addiction as an SSI disability category, evaluating needle exchange as an HIV prevention strategy, and investigating interventions for drug-involved offenders. In recent years, my work has focused on tobacco dependence in addictions treatment, because of the high rate of smoking in this population, because of the known health consequences, and because of the increasing evidence that quitting smoking in addictions treatment also improves drug abuse outcomes.
 

Research Funding

  • September 30, 2013 - August 31, 2017 - Marketing, FDA communication, tobacco perceptions and use in addiction treatment , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01DA036066
  • September 29, 1994 - May 31, 2016 - Treatment for Complex Patients: Continuing and Extended Care , Principal Investigator . Sponsor: NIH, Sponsor Award ID: P50DA009253
  • April 20, 2006 - March 31, 2012 - Organizational Change and Nicotine Dependence Treatment , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01DA020705
  • August 1, 2009 - July 31, 2011 - Impact of Core Implementation Components on Adoption , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01DA025600

Education

Washington State University, Pullman, WA, BS, 1977, Psychology
Fort Hays State University, Hays, KS, MS, 1982, Clinical Psychology
Washington State University, Pullman, WA, PhD, 1987, Clinical Psychology
University of California, San Francisco, CA, Postdoc Fellow, 1987-1988, Behavioral Medicine
University of California, San Francisco, Research Fellow, 1988-1990, AIDS Prevention Studies
University of California, Berkeley, CA, MPH, 1990, Epidemiology

Selected Publications

  1. Fu M, Castellano Y, Laroussy K, Baena A, Margalef M, Feliu A, Galimany-Masclans J, Puig-Llobet M, Moreno-Arroyo C, Sancho R, Bueno A, López A, Guydish J, Fernández E, Martínez C. Passive exposure and perceptions of smoke-free policies in hospital and university campuses among nursing students: A cross-sectional multicenter study. Tob Induc Dis. 2023; 21:93.  View on PubMed
  2. Guydish J, McCuistian C, Hosakote S, Le T, Masson CL, Campbell BK, Delucchi K. A cluster-randomized trial of a brief multi-component intervention to improve tobacco outcomes in substance use treatment. Subst Abuse Treat Prev Policy. 2023 Jun 16; 18(1):34.  View on PubMed
  3. Martínez C, Lisha N, McCuistian C, Straus E, Delucchi K, Guydish J. Corrigendum: Comparing client and staff reports on tobacco-related knowledge, attitudes, beliefs and services provided in substance use treatment. Tob Induc Dis. 2023; 21:59.  View on PubMed
  4. Campbell BK, Le T, Pagano A, McCuistian C, Woodward-Lopez G, Bonniot C, Guydish J. Addressing nutrition and physical activity in substance use disorder treatment: Client reports from a wellness-oriented, tobacco-free policy intervention. Drug Alcohol Depend Rep. 2023 Jun; 7:100165.  View on PubMed
  5. Martínez C, Lisha N, McCuistian C, Strauss E, Deluchi K, Guydish J. Comparing client and staff reports on tobacco-related knowledge, attitudes, beliefs and services provided in substance use treatment. Tob Induc Dis. 2023; 21:45.  View on PubMed
  6. Feliu A, Fernández E, Castellano Y, Enríquez M, Saura J, Cabezas C, Colom J, Suelves JM, Pla M, Parejo M, Mondon S, Barrio P, Andreu M, Raich A, Bernabeu J, Vilaplana J, Roca X, Bautista P, Guydish J, Martínez C, group of clinicians involved in the recruitment of the study. Tobacco cessation among smokers under substance use treatment for alcohol and/or cannabis: study protocol and pilot study. Addict Sci Clin Pract. 2022 Nov 30; 17(1):66.  View on PubMed
  7. Masson CL, Gubner NR, Benowitz N, Hosakote S, Le T, Guydish JR. Lifetime use of non-nicotine drugs in electronic cigarette devices among a sample of individuals in substance use disorder treatment. Addict Behav Rep. 2022 Dec; 16:100465.  View on PubMed
  8. Pagano A, McCuistian C, Le T, Campbell BK, Delucchi K, Woodward-Lopez G, Guydish J. Smoking Behavior and Wellness among Individuals in Substance Use Disorder Treatment. J Psychoactive Drugs. 2022 Jul 09; 1-12.  View on PubMed
  9. Fokuo JK, McCuistian CL, Masson CL, Gruber VA, Straus E, Wong J, Guydish JR. Pre-implementation Assessment of Tobacco Cessation Interventions in Substance Use Disorder Residential Programs in California. Subst Use Misuse. 2022; 57(9):1345-1355.  View on PubMed
  10. Martínez C, Feliu A, Torres N, Nieva G, Pinet C, Raich A, Mondon S, Barrio P, Andreu M, Hernández-Ribas R, Vicens J, Costa S, Suelves JM, Vilaplana J, Enríquez M, Alaustre L, Vilalta E, Subirà S, Bruguera E, Castellano Y, Saura J, Guydish J, Fernández E, Ballbè M. Acceptability and participation predictors for a pragmatic randomized controlled trial to test a smoking cessation intervention after discharge from mental health wards. Drug Alcohol Depend. 2022 05 01; 234:109390.  View on PubMed
  11. Campbell BK, Le T, McCuistian C, Hosakote S, Kapiteni K, Guydish J. Implementing tobacco-free policy in residential substance use disorders treatment: Practice changes among staff. Drug Alcohol Depend Rep. 2022 Mar; 2:100033.  View on PubMed
  12. Fitzpatrick CM, Anderson BT, Agin-Liebes G, Guydish J. Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms. J Psychoactive Drugs. 2022 Sep-Oct; 54(4):324-327.  View on PubMed
  13. McCuistian C, Kapiteni K, Le T, Safier J, Delucchi K, Guydish J. Reducing tobacco use in substance use treatment: An intervention to promote tobacco-free grounds. J Subst Abuse Treat. 2022 04; 135:108640.  View on PubMed
  14. McCuistian C, Le T, Delucchi K, Pagano A, Hosakote S, Guydish J. Racial/Ethnic Differences in Tobacco Use and Cessation Services among Individuals in Substance Use Treatment. J Psychoactive Drugs. 2021 Nov-Dec; 53(5):483-490.  View on PubMed
  15. Martínez C, Castellano Y, Laroussy K, Fu M, Baena A, Margalef M, Feliu A, Aldazabal J, Tigova O, Galimany J, Llobet MP, Moreno C, Bueno A, López A, Guydish J, Fernández E. Knowledge, attitudes, and training in tobacco dependence and cessation treatment among Nursing Students in Catalonia (ECTEC Study): Cross-Sectional Study. Int J Ment Health Addict. 2023 Apr; 21(2):1041-1056.  View on PubMed
  16. Nguyen N, Kapiteni K, Straus ER, Guydish J. Factors associated with dual and polytobacco use among people in residential substance use disorder treatment. Am J Addict. 2021 09; 30(5):496-504.  View on PubMed
  17. Accurso EC, Mu KJ, Landsverk J, Guydish J. Adaptation to family-based treatment for Medicaid-insured youth with anorexia nervosa in publicly-funded settings: Protocol for a mixed methods implementation scale-out pilot study. J Eat Disord. 2021 Aug 13; 9(1):99.  View on PubMed
  18. Masson CL, McCuistian C, Straus E, Elahi S, Chen M, Gruber VA, Le T, Guydish J. COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs. Drug Alcohol Depend. 2021 08 01; 225:108812.  View on PubMed
  19. Guydish J, Le T, Hosakote S, Straus E, Wong J, Martínez C, Delucchi K. Tobacco use among substance use disorder (SUD) treatment staff is associated with tobacco-related services received by clients. J Subst Abuse Treat. 2022 01; 132:108496.  View on PubMed
  20. Masson CL, Le T, Hosakote S, Fokuo JK, Gubner NR, Shingle M, Guydish J. Correlates of e-cigarette use for smoking cessation among clients in residential substance use disorder treatment. Addict Behav. 2021 08; 119:106947.  View on PubMed

Go to UCSF Profiles, powered by CTSI